Duchenne's Muscular Dystrophy (DMD) Completed Phase 2 Trials for Eteplirsen (DB06014)

Also known as: Duchenne's Muscular Dystrophy / Duchenne Muscular Dystrophy (DMD) / Duchenne Muscular Dystrophy / Muscular Dystrophy, Duchenne / Muscular dystrophy

IndicationStatusPhase
DBCOND0066749 (Duchenne's Muscular Dystrophy (DMD))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01540409Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular DystrophyTreatment
NCT02420379Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular DystrophyTreatment
NCT01396239Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy PatientsTreatment